Abstract: Methods and apparatus disclosed herein relate to graphical representation of oxygenation of an organism. In various embodiments, one or more measured physiological parameters of an organism may be analyzed. Based on the analysis, a graphical user interface (GUI) may be rendered. The GUI may convey oxygenation of an organism visually as a continuous physiological flow graphical element (236) that passes through four quadrants in a cycle. In various embodiments, each quadrant includes an abscissa and an ordinate that represent a relationship between at least two of the measured physiological parameters. In various embodiments, for at least some of the four quadrants, the ordinate of one quadrant comprises the abscissa of the next quadrant of the cycle. In various embodiments, the GUI may be used to simulate changes in a physiological parameter.

Abstract: Methods and apparatus disclosed herein relate to graphical representation of patient hemodynamic state. In various embodiments, one or more measured physiological parameters of a patient may be analyzed. Based on the analysis, a graphical user interface (GUI) may be rendered. The GUI may include a figure-eight schematic (222, 1222) that represents a circulatory system of the patient. The figure-eight schematic may include: a first loop (224, 1224) that represents pulmonary circulation of the patient; a second loop (226, 1226) that represents systemic circulation of the patient; and a central object (228, 1228) that connects the first and second loops represents a heart of the patient. In various embodiments, each of the first and second loops includes multiple arc fragments, with each arc fragment being shaped to convey one or more of the measured physiological parameters of the patient.

Abstract: Methods and apparatus disclosed herein relate to graphical representation of change in patient state. In various embodiments, one or more measured physiological parameters of a patient may be analyzed, which includes determining a rate of change in one or more of the measured physiological parameters over time. Based on the analysis, a graphical user interface (GUI) may be rendered. The graphical user interface may include a comet-shaped graphical element that conveys the rate of change in the one or more of the physiological parameters over time. For example, the comet-shaped graphical element may include a tail that is sized or shaped to convey the direction and the rate of change.

Abstract: The present invention relates to a modified OSB board (oriented strand board) with an upper side and a lower side. The upper and/or lower side of the board are coated with at least two paper layers. The first paper layer is impregnated with at least one resin and the second paper layer is a raw paper layer. The invention relates further to a construction wall for a house building system, to a partition wall for a house building system and a house building system.

Abstract: The present invention relates to a modified OSB board (oriented strand board) with an upper side and a lower side. The upper and/or lower side of the board are coated with at least two paper layers. The first paper layer is impregnated with at least one resin and the second paper layer is a raw paper layer. The invention relates further to a construction wall for a house building system, to a partition wall for a house building system and a house building system.

Abstract: Derivatives of bladder epithelial antiproliferative factor and methods of using them are disclosed. In specific embodiments, the glycopeptide compositions are useful for the treatment and/or prevention of medical conditions, including cancer. In other embodiments, there are compositions and methods related to treatment of bladder conditions. In particular embodiments, the glycopeptide comprises D-pipecolic acid or L-pipecolic acid.

Abstract: Derivatives of bladder epithelial antiproliferative factor and methods of using them are disclosed. In specific embodiments, the glycopeptide compositions are useful for the treatment and/or prevention of medical conditions, including cancer. In other embodiments, there are compositions and methods related to treatment of bladder conditions. In particular embodiments, the glycopeptide comprises D-pipecolic acid or L-pipecolic acid.